Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PeptiDream | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥214.27B | 14.5x | 0.03 | JP¥1,659 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GNI | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥155.16B | -153.4x | 1.38 | JP¥3,085 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.3% Upside | Upgrade to Pro+ | |
Sanbio Company | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥152.82B | -98.8x | -2.94 | JP¥2,125 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -23.3% Downside | Upgrade to Pro+ | |
Takara Bio | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥99.46B | 95.6x | -3.19 | JP¥826 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.5% Upside | Upgrade to Pro+ | |
Heartseed | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥74.03B | 129.9x | JP¥3,310 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Healios K K | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥68.49B | -14.6x | -0.38 | JP¥679 | 11.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.3% Upside | Upgrade to Pro+ | |
Shin Nippon Biomed Lab | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥56.62B | 11.4x | -1.05 | JP¥1,365 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharma Foods | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥24.4B | 106.4x | -1.15 | JP¥845 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
3-D Matrix | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥22.61B | -8.2x | 0.01 | JP¥205 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AnGes | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥20.01B | -0.6x | 0 | JP¥60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chordia Therapeutics | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥13.73B | JP¥209 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Kidswell Bio | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥12.2B | -534.2x | JP¥279 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Chiome Bioscience | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥10.1B | -9.3x | -0.28 | JP¥149 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medinet | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥10.06B | -1.1x | JP¥38 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Tsubota Laboratory | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥9.82B | 50.3x | 0.36 | JP¥385 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NanoCarrier | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥9.81B | -11.7x | 1.74 | JP¥139 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MediciNova | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥8.88B | -5.6x | 0.18 | JP¥187 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PRISM BioLab | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥8.02B | JP¥226 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
NoileImmune Biotech | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥7.75B | -7.9x | -0.67 | JP¥175 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OncoTherapy | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥7.72B | -9x | -0.2 | JP¥28 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Linical Co Ltd | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥7.41B | 0.05 | JP¥328 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Modalis | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥6.77B | -3.3x | -0.07 | JP¥90 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TMS | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥6.65B | -10.3x | -0.27 | JP¥165 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BrightPath Biotherapeutics | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.97B | -4.7x | -0.22 | JP¥66 | 6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
D.Western Therapeutics Institute | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.84B | -4.4x | -0.58 | JP¥130 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carna Biosciences | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.67B | -2.4x | 0.02 | JP¥297 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kringle | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.66B | -7.6x | -0.41 | JP¥828 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cyfuse Biomedical KK | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.64B | -9.4x | 0.33 | JP¥681 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ribomic | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.17B | -4.6x | -0.4 | JP¥116 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Human Metabolome Tech | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥4.46B | 14.2x | 1.17 | JP¥769 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Veritas In Silico | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥4.11B | -19.2x | JP¥671 | 5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Funpep | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥3.72B | -2.5x | 0.07 | JP¥110 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PhoenixBio Co | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥1.57B | -3.5x | 0 | JP¥388 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |